Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells.
Pharmacol Res
; 166: 105491, 2021 04.
Article
em En
| MEDLINE
| ID: mdl-33582247
Palavras-chave
3,8-Di-O-methylellagic acid 2-O-glucoside; 3,8-Di-O-methylellagic acid 2-O-glucoside (PubChem CID: 75253873); 3-O-methylellagic acid (PubChem CID: 13915428); Acute erythroid leukemia; Differentially regulated networks; Ellagic acid (PubChem CID: 5281855); Non-coding RNAs; Whole-transcriptome sequencing
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Leucemia Eritroblástica Aguda
/
Sanguisorba
/
Antineoplásicos Fitogênicos
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article